Faculty Collaboration Database -

CURRICULUM VITAE

Kaitlin Annunzio DO

Assistant Professor
Department of Medicine
Division of Medicine Hematology Oncology


OFFICE ADDRESS:
9200 West Wisconsin Avenue

Milwaukee, WI 53226


EDUCATION:
2007 - 2011 B.S. in Biochemistry, University of Wisconsin – Madison, Madison, WI
2012 - 2013 Bachelor in Medical Sciences coursework, Dominican University, River Forest, IL
2014 - 2018 Doctor of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine at Seton Hill, Greensburg, PA
2022 - 2024 Master of Medical Science, The Ohio State University, Columbus, OH


POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
2018 - 2021 Resident, Internal Medicine, Froedtert and the Medical College of Wisconsin, Milwaukee, WI
2021 - 2024 Clinical Fellow, Hematology and Medical Oncology, The Ohio State University, Columbus, OH


FACULTY APPOINTMENTS:
2024 - Present Assistant Professor, Medicine, Hematology & Oncology, Medical College of Wisconsin


ADMINISTRATIVE APPOINTMENTS:
2014 - 2016 Secretary and Vice President, Student Government Association, Lake Erie College of Osteopathic Medicine at Seton Hill
2015 - 2016 Sigma Sigma Phi Executive Board, Lake Erie College of Osteopathic Medicine at Seton Hill
2015 - 2016 Student Osteopathic Surgery Club President, Lake Erie College of Osteopathic Medicine at Seton Hill


SPECIALTY BOARDS AND CERTIFICATION:


Certificates	Issued By	Issue Date	Expiration
Internal Medicine	ABIM	2021	None
Basic Life Support Certification		2022	None
Advanced Cardiovascular Life Support Certification		2022	None
Medical Oncology	ABIM	2024	None


Licensure	Number	Issue Date	Expiration
Wisconsin Medical License		2020	None
Ohio Medical License		2023	None


AWARDS AND HONORS:
2016 - 2017 Merit based tuition scholarship, Lake Erie College of Osteopathic Medicine Academic Scholarship
2016 Silver Award Winner - Recognized for completing between 50-100 community service hours over one year, Council of Osteopathic Student Government President’s Translating Osteopathic Understanding into Community Health (TOUCH)
2023 Merit Based Award, American Society of Hematology


MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
2015 - Present Sigma Sigma Phi Honors Osteopathic Fraternity
2019 - Present American Society of Clinical Oncology
2021 - Present American Society of Hematology
2023 - Present American Society for Transplantation and Cellular Therapy


LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2021 - Present Member, Wellness Committee, Hematology and Oncology Fellowship
2021 - Present Member, Healthcare Disparities Committee, Hematology and Oncology Fellowship
2023 - Present Member, Program Evaluation Committee, Hematology and Oncology Fellowship
2023 - Present Member, Education Committee, Hematology and Oncology Fellowship

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:


Active
Peer Review
Title:	A phase I study of N-803 as maintenance therapy following CD19 directed CAR-T cell therapy in patients with relapsed/refractory B-cell non-Hodgkin lymphoma
Role & Effort:	Co-Investigator, Protocol concept development and writing.
PI:	Naren Epperla


INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
National
BMT M&M Conference, The Ohio State University, Columbus, OH, 11/21/2021
Fellowship Journal Club, The Ohio State University, Columbus, OH, 01/10/2022
"Burkitt Lymphoma.”, Case Review Conference, The Ohio State University, Columbus, OH, 02/08/2022
"Hematology 2 Orientation.”, Fellowship Orientation Bootcamp, The Ohio State University, Columbus Ohio, 07/14/2022
“Lymphoma Management and Workup.”, Resident Lecture Series, The Ohio State University, Columbus, OH, 11/07/2022
“Topics in DLBCL.”, Case Review Conference, The Ohio State University, Columbus, OH, 12/22/2022
Research Boot Camp on Research Methods and Design, The Ohio State University, 2022 - 2023
Palliative Care Communication Workshops, The Ohio State University, 2022 - 2023
Clinical Trials Workshop, The Ohio State University, 2022 - 2023
“Lymphoma Management and Workup.”, Resident Lecture Series, The Ohio State University, Columbus, OH, 01/23/2023
“Anthracycline Induced Cardiotoxicity.”, Fellowship M&M, The Ohio State University, Columbus, OH, 04/24/2023
“Impact of circulating lymphoma: a multicenter review and the role of N-803 in post CAR T-cell maintenance therapy.”, Fellowship Research Presentation, he Ohio State University, Columbus, OH, 06/13/2023
“Fellowship Orientation.”, Fellowship Orientation Bootcamp, The Ohio State University, Columbus, OH, 07/03/2023 - 07/04/2023
“Fellowship Procedure Training.”, The Ohio State University, Columbus, OH, 07/07/2023
“Hematology Consults.”, Fellowship Orientation Bootcamp, The Ohio State University, Columbus, OH, 07/20/2023
Principal Investigator Training, 2023

Regional
"Relapsed/refractory indolent lymphoma: What’s new?", 2025 Controversies in Hematologic Malignancies Symposium, Milwaukee, WI, 03/01/2025


INSTITUTIONAL QUALITY & PROCESS IMPROVEMENT ACTIVITIES:
2021 - Present Reducing Inappropriate Inpatient Thrombophilia Testing: A Hematology/Oncology Fellowship QI Initiative, The Ohio State University


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Annunzio K, Ozga M, Huang Y, Anghelina M, Bhat SA, Blachly JS, Grever MR, Lozanski G, Neal J, Shindiapina P, Rogers KA. Single-center study of outcomes of patients with hairy cell leukemia who contracted SARS-CoV-2. EJHaem. 2023 Nov;4(4):1200-1202. PMCID: PMC10660372
2. Steiner RE, Hwang SR, Khurana A, Habermann TM, Epperla N, Annunzio K, Allen PB, Baird K, Paulino D, Alderuccio JP, Lossos IS, David K, Evens AM, Pandya K, Bair SM, Kamdar M, Ba Aqeel S, Torka P, Lynch R, Smith S, Feng L, Noorani M, Ahmed S, Nair R, Vega F, Wu S, Fang P, Pinnix CC, Gunther JR, Dabaja BS, Lee HJ. Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma. Blood Adv. 2023 Dec 26;7(24):7485-7493. PMCID: PMC10758726
3. Bowers JT, Anna J, Bair SM, Annunzio K, Epperla N, Pullukkara JJ, Gaballa S, Spinner MA, Li S, Messmer MR, Nguyen J, Ayers EC, Wagner CB, Hu B, Di M, Huntington SF, Furqan F, Shah NN, Chen C, Ballard HJ, Hughes ME, Chong EA, Nasta SD, Barta SK, Landsburg DJ, Svoboda J. Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort. Blood Adv. 2023 Nov 14;7(21):6630-6638. PMCID: PMC10628810
4. Epperla N, Welkie RL, Torka P, Shouse G, Karmali R, Shea L, Anampa-Guzmán A, Oh TS, Reaves H, Tavakkoli M, Lindsey K, Greenwell IB, Hansinger E, Thomas C, Chowdhury SM, Annunzio K, Christian B, Barta SK, Geethakumari PR, Bartlett NL, Herrera AF, Grover NS, Olszewski AJ. Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study. J Hematol Oncol. 2023 May 08;16(1):49. PMCID: PMC10165748
5. Annunzio K, Cackovic M, Bond D, Sawalha Y, Voorhees TJ, Hanel W, Alinari L, Baiocchi R, Reneau J, Brammer J, Maddocks K, Christian B, Epperla N. Treatment of primary mediastinal B-cell lymphoma with dose-adjusted REPOCH during pregnancy. Blood Adv. 2023 May 23;7(10):2241-2244. PMCID: PMC10196908
6. Cohn JE, Rethy K, Prasad R, Mae Pascasio J, Annunzio K, Zwillenberg S. Pediatric Bronchogenic Cysts: A Case Series of Six Patients Highlighting Diagnosis and Management. J Invest Surg. 2020 Jul;33(6):568-573.
7. Nalin A, Zhao Q, Voorhees T, Bond D, Sawalha Y, Hanel W, Sigmund A, Annunzio K, Alinari L, Baiocchi R, Maddocks K, Jones D, Christian B, Epperla N. Impact of circulating lymphoma cells at diagnosis on outcomes in patients with Waldenstrom macroglobulinemia. Front Oncol. 2023;13:1264387. PMCID: PMC10533994
8. Iqbal M, Jagadeesh D, Chavez J, Khurana A, Rosenthal A, Craver E, Epperla N, Li Z, Isufi I, Awan FT, Dholaria BR, Maakaron JE, Sandoval-Sus JD, Mishra R, Saha A, Annunzio K, Bhaskar ST, Sumransub N, Fijalka A, Ivanov SA, Lin Y, Kharfan-Dabaja MA. Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy. Bone Marrow Transplant. 2024 Feb;59(2):211-216.
9. Annunzio K, Grover NS, Welkie RL, Torka P, Watkins MP, Anampa-Guzmán A, Tavakkoli M, Oh TS, Reves H, Jones D, Hanel W, Christian B, Ramakrishnan Geethakumari P, Karmali R, Barta SK, Bartlett NL, Olszewski AJ, Epperla N. Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study. Blood Adv. 2023 Nov 28;7(22):6839-6843. PMCID: PMC10679805
10. Epperla N, Zhao Q, Karmali R, Torka P, Shea L, Oh TS, Anampa-Guzmán A, Reves H, Tavakkoli M, Greenwell IB, Hansinger E, Umyarova E, Annunzio K, Sawalha Y, Christian B, Thomas C, Barta SK, Geethakumari PR, Bartlett NL, Grover NS, Olszewski AJ. Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study. Blood Adv. 2023 Sep 12;7(17):5038-5046. PMCID: PMC10471932
11. Kharfan-Dabaja MA, Mohty R, Easwar N, Johnston P, Iqbal M, Epperla N, Yared J, Ahmed N, Hamadani M, Beitinjaneh A, Narkhede M, Jagadeesh D, Ramakrishnan Geethakumari P, Dholaria B, Gergis U, Munoz J, Sandoval-Sus J, Locke FL, Fein J, Khurana A, Ayala E, Annunzio K, Rapoport AP, Lutfi F, Akhtar OS, Lekakis L, Mehta A, Oluwole OO, Logue J, Jain MD, Shore T, Durani U, Alhaj Moustafa M, McGuirk J, Lin Y, Yamshon S, Chavez JC. Chimeric antigen receptor T cell therapy in octogenarians with B cell lymphoma: a real-world US multicenter collaborative study. Bone Marrow Transplant. 2025 May;60(5):632-639.
12. Zelikson V, Gurumurthi A, Sawalha Y, Annunzio K, Saha A, Dong N, Qualls D, Amoozgar B, Kahl B, Baird J, Challa P, Huntington SF, Santos J, Bair S, Narkhede M, Li S, Frosch Z, Ho C, Smith SD, Winter A, Landsburg D, Furqan F, Hamadani M, Baird K, Romancik J, Alharthy H, Law J, Bojanini L, Advani R, Hu B, Johnson PC, Grover NS, Merril M, Crombie JL, Shafagati N, Sterling C, Nastoupil LJ, Epperla N, Ayers EC. Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: a realworld analysis from 21 US centers. Haematologica. 2025 Mar 01;110(3):706-714. PMCID: PMC11873705
13. St-Pierre, Bhatta S, Doukjas P, Jenkin, Annunzio K, Rojek A, Gibson A, Tiger YK, McCall B, Alhamad K, Hansen A, Alderuccio J, Adewale O, Patel K, Trabolsi A, Lossos I, Fitzgerald L, Ollila T, Matasar M, Kline J, Karmali R, Epperla N. Impact of extranodal involvement of CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma—Results from a multicenter cohort study. Blood Cancer J. 15, 110 (2025).
14. Epperla N., Shouse G., Grover N.S., Torka P, Annunzio K, Watkins M, Anampa-Guzman A, Christian B, Thomas C, Barta S, Ramakrishnana P, Karmali R, Bartlett N, Olszewski A. Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma - a US multisite study. Exp Hematol Oncol 14, 73 (2025).
15. Torka P., Grover N.S., Voorhees T.J., Karmali R., Annunzio K., Watkins M.P., Anampa-Guzmán A., Reves H., Tavakkoli M., Christian B., Thomas C., Barta S.K., Geethakumari P.R., Bartlett N.L., Shouse G., Olszewski A.J. and Epperla N. (2025), Impact of Age on Biology, Presentation and Outcomes in Marginal Zone Lymphoma: Results From a Multicenter Cohort Study. Hematological Oncology, 43: e70087.
16. Annunzio K, Bhatta S, Hanel W, et al. Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patients. Hematol Oncol. 2024;e3278.
17. Reem Karmali, Rushad Machhi, Narendranath Epperla, Geoffrey Shouse, Jason T. Romancik, Tamara K Moyo, Vaishalee P Kenkre, Thomas A Ollila, Lindsey A. Fitzgerald, Brian T. Hess, Kevin A. David, Ishan Roy, Joanna C Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul S Bhansali, Elyse I. Harris, Jieqi Liu, Imran A. Nizamuddin, Shuo Ma, Jonathan Moreira, Jane N Winter, Barbara Pro, Deborah M. Stephens, Alexey V. Danilov, Nirav N. Shah, Jonathon B Cohen, Stefan K Barta, Pallawi Torka, Leo I. Gordon; Impact of Race and Social Determinants of Health on Outcomes in Patients with Aggressive B-cell nHL Treated with CAR-T. Blood Adv 2024; bloodadvances.2023011996
18. Narendranath Epperla, Qiuhong Zhao, Tamara Moyo, Marcus P. Watkins, Montreh Tavakkoli, Celeste Bello, Pallawi Torka, Nishitha Reddy, Colin Thomas, Kaitlin Annunzio, Beth Christian, Stefan K. Barta, Geoffrey Shouse, Adam J. Olszewski, Nancy L. Bartlett; Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: a real-world analysis. Blood Adv 2024; 8 (3): 549–552.
19. Epperla, N., Feng, L., Shah, N.N. et al. Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study. J Hematol Oncol 16, 111 (2023).
20. Annunzio K, Shah NN. Sequencing CAR-Ts in Relapsed DLBCL: Is More Always Better? Transplant Cell Ther. 2025 Nov;31(11):849-850.
21. Melody M, Grover N, Franco S, Romancik J, Cortese M, Moyo TK, Bhansali RS, Ollila T, Kenkre V, Fitzgerald L, Hess B, Matasar M, Shouse G, Annunzio K, Herr MM, Davis JA, Jesme C, Pelcovits A, Moreira J, Ma S, Winter JN, Lin A, Danilov A, Roy I, Barta SK, Gordon LI, Stephens D, Cohen JB, Epperla N, Karmali R. Outcomes of bispecific antibodies after CAR T-cell failure for large B-cell lymphoma: results from the ABC consortium. Blood Adv. 2026 Jan 13;10(1):228-232. PMCID: PMC12811448
22. St-Pierre F, Bhatta S, Doukas PG, Jenkin M, Annunzio K, Rojek AE, Gibson A, Tiger YK, McCall B, Alhamad K, Hansen A, Alderuccio JP, Adewale O, Patel K, Trabolsi A, Lossos IS, Fitzgerald L, Ollila TA, Matasar MJ, Kline J, Karmali R, Epperla N. Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma-Results from a multicenter cohort study. Blood Cancer J. 2025 Jun 21;15(1):110. PMCID: PMC12182562
23. Trabolsi A, Han S, Epperla N, Annunzio K, Baidoun F, Alhaj Moustafa M, Morgenstern-Kaplan D, Doukas P, St-Pierre F, McCall B, Fitzgerald L, Sandoval-Sus J, Dalal S, Reis IM, Chapman-Fredricks JR, Kim SH, Au C, Otto NB, Alhamad K, Ollila T, Karmali R, Shouse G, Lossos IS, Alderuccio JP. Outcomes of follicular lymphoma with leukemic phase in the modern era: results from a large multicenter study. Blood Neoplasia. 2025 Feb;2(1):100063. PMCID: PMC12082143
24. Epperla N, Shouse G, Grover NS, Torka P, Annunzio K, Watkins M, Anampa-Guzmán A, Christian B, Thomas C, Barta SK, Geethakumari PR, Karmali R, Bartlett NL, Olszewski AJ. Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma - a US multisite study. Exp Hematol Oncol. 2025 May 14;14(1):73. PMCID: PMC12079943
25. Torka P, Grover NS, Voorhees TJ, Karmali R, Annunzio K, Watkins MP, Anampa-Guzmán A, Reves H, Tavakkoli M, Christian B, Thomas C, Barta SK, Geethakumari PR, Bartlett NL, Shouse G, Olszewski AJ, Epperla N. Impact of Age on Biology, Presentation and Outcomes in Marginal Zone Lymphoma: Results From a Multicenter Cohort Study. Hematol Oncol. 2025 May;43(3):e70087. PMCID: PMC12013245
26. Chowdhury SM, Bhatta S, Voorhees TJ, Annunzio K, Bond DA, Sawalha Y, Sigmund A, Hanel W, Sehgal L, Alinari L, Baiocchi R, Maddocks K, Christian B, Jones D, Epperla N. Impact of circulating lymphoma cells at diagnosis on outcomes in patients with newly diagnosed de novo diffuse large B-cell lymphoma. J Hematol Oncol. 2025 Jan 05;18(1):4. PMCID: PMC11702192
27. Grover NS, Annunzio K, Watkins M, Torka P, Karmali R, Anampa-Guzmán A, Oh TS, Reves H, Tavakkoli M, Hansinger E, Christian B, Thomas C, Barta SK, Geethakumari PR, Bartlett NL, Shouse G, Olszewski AJ, Epperla N. Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study. Blood Cancer J. 2024 Oct 18;14(1):182. PMCID: PMC11489653

Abstracts
1. Roy I, Epperla N, Shouse G, Romancik J, Moyo T, Kenkre V, Ollila T, Fitzgerald L, Hess B, Evens A, Zurko J, Chowdhury S, Annunzio K, Ferdman R, Bhansali R, Harris E, Sorrell M, Liu J, Nizamuddin I, Moreira J, Ma S, Winter J, Pro B, Stephens D, Danilov A, Shah N, Cohen J, Barta S, Torka P, Gordon L, Karmali R. Consensus cachexia criteria are independently linked to progression free and overall survival in multi-site analysis of patients with aggressive B-cell lymphomas treated with CAR T-cell therapy. Presented at: 64th American Society of Hematology Annual Meeting & Exposition; 2022 December 12, New Orleans, LA.
2. Epperla N, Li R, Torka P, Shea L, Karmali R, Anampa-Guzman A, Oh T, Lindsey K, Greenwell B, Chowdhury S, Annunzio K, Christian B, Shouse G, Herrera A, Bartlett N, Grover N, Olszewski A. Early relapse within 24 months after frontline systemic therapy (POD24) is associated with worse survival in patients with marginal zone lymphoma: A multisite study. Presented at: 64th American Society of Hematology Annual Meeting & Exposition; 2022 December 12, New Orleans, LA.
3. Zurko J, Shouse G, Torka P, Moyo T, Romantik J, Nizamuddin I, Annunzio K, Liu J, Barta S, Ferdman R, Bhansali R, Cohen J, Chowdhury S, Shah N, Harris E, Kenkre V, Sorrell M, Hess B, Stephens D, Fitzgerald L, Ollila T, Roy I, Ma S, Winter J, Pro B, Moreira J, Gordan L, Danilov A, Evens A, Epperla N, Karmali R. Double Hit/Double Expressor Lymphomas: A multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy. Presented at: 64th American Society of Hematology Annual Meeting & Exposition; 2022 December 10, New Orleans, LA.
4. St-Pierre F, Alrifai T, Alhamad K, McCall B, Annunzio K, Mi X, Doukas P, Schoen A, Fu L, Au C, Otto N, Rojek A, Kline J, Villasboas Bisneto J, Cohen J, Matasar M, Epperla N, Ollila T, Fitzgerald L, Danilov A, Shouse G, Trabolsi A, Alderuccio J, Lossos I, Kim S, Karmali R. Outcomes in primary GI follicular lymphoma: Results from a North American extranodal lymphoma consortium. Presented at International conference on malignant lymphoma; 2023 June 16, Lugano, Switzerland
5. Bowers J, Anna J, Blair S, Annunzio K, Epperla N, Pullukkara J, Gaballa S, Spinner M, Li S, Messmer M, Nguyen J, Ayers E, Wagner C, Hu B, Di M, Huntington S, Furqan F, Shah N, Chen C, Svoboda J. Brentuximab vedotin + AVD for newly diagnosed classic Hodgkin lymphoma (cHL): Incidence and management of peripheral neuropathy in a multi-institution cohort. Presented at: 2023 ASCO Annual Meeting; 2023 June 5, Chicago, IL.
6. Annunzio K, Hu E, Huang Y, Grantier C, Grever M, Hoffman C, Kittai A, Lozanski G, Lucas M, Moran M, Reid M, Shindiapina P, Suresh S, Woyach J, Bhat S, Rogers K. Efficacy of COVID vaccination is patients with chronic lymphocytic leukemia. Presented at: 2023 ASCO Annual Meeting; 2023 June 5, Chicago, IL.
7. Karmali R, Epperla N, Shouse G, Romancik J, Moyo T, Kenkre V, Ollila T, Fitzgerald L, Hess B, Evens A, Roy I, Zurko J, Chowdhury S, Annunzio K, Ferdman R, Bhansali R, Harris E, Sorrell M, Liu J, Nizamuddin I, Ma S, Moreira J, Winter J, Pro B, Stephens D, Danilov A, Shah N, Cohen J, Barta S, Torka P, Gordon L. Impact of race and social determinants of health outcomes in patients with aggressive B-cell lymphomas treated with chimeric antigen receptor T-cell (CART) therapy. Presented at: 64th American Society of Hematology Annual Meeting & Exposition; 2022 December 12, New Orleans, LA.
8. Iqbal M, Khurana A, Chavez J, Rosenthal A, Li Z, Craver E, Aditi S, Epperla N, Annunzio K, Awan F, Isufi I, Dholeria B, Bhaskar S, Maakaron J, Sumransub N, Fijalka A, Sandoval-sus J, Ivanov S, Lin Y, Kharfan-Dabaja M. Efficacy of CD19 directed therapies in large B-cell lymphoma (LBCL) relapsing after chimeric antigen receptor (CAR) T-cell therapy. Presented at: 64th American Society of Hematology Annual Meeting & Exposition; 2022 December 12, New Orleans, LA.
9. Annunzio K, Grover N, Li R, Jones D, Hanel W, Christian B, Olszewski A, Epperla N. Impact of circulating lymphoma at diagnosis on outcomes in patients with marginal zone lymphoma. Presented at: 64th American Society of Hematology Annual Meeting & Exposition; 2022 December 10, New Orleans, LA.
10. Mehdi M, Annunzio K, Taylor B, Szabo A, Shreenivas A, Chakrabarti S, Thomas J, Tsai S, Christians K, Evans D, Clarke C, Hall W, Erickson B, Thapa B, Ahmed G, George B, Kamgar M. Target therapy (TT) in patients with KRAS wildtype (WT) pancreatic ductal adenocarcinoma (PDAC) produces durable response. Presented at: ASCO Gastrointestinal Cancers Symposium; 2022 January, San Francisco, CA.
11. Ahmed G, Annunzio K, Szabo A, Eastwood D, Thapa B, Taylor B, Tsai S, Christians K, Clarke C, Evans D, Hall W, Erickson B, Kamgar M, George B. Clinical outcomes in pancreatic ductal adenocarcinoma (PDAC) patients with underlying autoimmune disease (AID). Presented at: ASCO Annual Meeting; 2021 June, Virtual Meeting.
12. Mehi M, Kamgar M, George B, Szabo A, Annunzio K, Taylor B, Shreenivas A, Chakrabarti S, Thomas J, Tsai S, Christians K, Evans D, Clarke C, Hall W, Erickson B, Ahmed G, Thapa B. Impact of KRAS alterations in pancreatic ductal adenocarcinoma (PDAC). Presented at: ASCO Annual Meeting; 2021 June, Virtual Meeting.
13. Shreenivas A, Annunzio K, Kamgar M, Chakrabarti S, Thomas J, Madhaven S, Dua K, Khan A, Hall W, Erickson B, Chrsitians K, Clarke C, Evans D, Tsai S, Szabo A, Urrutia R, Zimmermann M, Reddi H, George B. Impact of KRAS alterations in localized pancreatic cancer (PC). Presented at: ASCO Gastrointestinal Cancers Symposium; 2021 January, San Francisco, CA.
14. Annunzio K, Griffiths C, Arapi I, Lasowski M, Singavi A, Dua K, Khan A, Ritch P, Kamrar M, Thomas J, Hall W, Erickson B, Tsai S, Christians K, Evans D, Urrutia R. Szabo A, George B. Impact of CDKN2A/B status in pancreatic cancer (PC). Presented at ASCO Gastrointestinal Cancers Symposium; 2020 January, San Francisco, CA.
15. Annunzio K. Methimazole induced agranulocytosis in the setting of amiodarone induced thyrotoxicosis. Presented at: American College of Physicians Wisconsin Chapter Annual Scientific Meeting; 2019 September 6, Wisconsin Dells, WI.
16. Annunzio K. The role of shoulder replacement surgery in the treatment of joint pain. Presented at: ACCA Student Symposium at Concordia University; 2014 April 13, River Forest, IL.
17. Annunzio K, Forest K. Determining ATP hydrolysis coordination in pseudomonas aeruginosa PILT. Presented at: University of Wisconsin – Madison Undergraduate Symposium; 2010 April 15, Madison WI.
18. Melody M, Epperla N, Cortese M, Romancik J, Moyo T, Kenkre V, Ollila T, Fitzgerald L, Hess B, David K, Annunzio K, Herr M, Bhansali R, Harris E, Davis J, Odetola O, Lin A, Ma S, Moreira J, Winter J, Stephens D, Danilov A, Shah N, Cohen J, Shouse G, Roy I, Barta S, Gordon L, Karmali R. Exploration of language as a barrier to the assessment and management of CAR T-cell therapy associated toxicities. Presented at 65th American Society of Hematology Annual Meeting & Exposition; 2023 December 9, San Diego, CA.
19. Epperla N, Annunzio K, Shouse G, Grover N, Torka P, Watkins M, Anampa-Guman A, Oh T, Reves H, Tavakkoli M, Hansinger E, Christian B, Thomas C, Barta S, Geethakumari P, Karmali R, Bartlett N, Olszewski A. Impact of maintenance rituximab following first-line systemic therapy on outcomes in patients with marginal zone lymphoma: real world evidence from 10 US Centers. Presented at 65th American Society of Hematology Annual Meeting & Exposition; 2023 December 9, San Diego, CA.
20. Epperla N, Annunzio K, Shouse G, Grover N, Torka P, Watkins M, Anampa-Guman A, Oh T, Reves H, Tavakkoli M, Hansinger E, Christian B, Thomas C, Barta S, Geethakumari P, Karmali R, Bartlett N, Olszewski A. Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma- a US multisite study. Presented at 65th American Society of Hematology Annual Meeting & Exposition; 2023 December 9, San Diego, CA.
21. Melody M, Epperla N, Shouse G, Romancik J, Moyo T, Kenkre V, Ollila T, Fitzgerald L, Hess B, David K, Annunzio K, Herr M, Bhansali R, Harris E, Davis J, Odetola O, Lin A, Moreira J, Ma S, Winter J, Stephens D, Danilov A, Shah N, Roy I, Barta S, Cortese M, Torka P, Cohen J, Gordon L, Karmali R. Immune reconstitution and infection patterns following CAR T-cell therapy in patients with aggressive lymphoma. Presented at 65th American Society of Hematology Annual Meeting & Exposition; 2023 December 9, San Diego, CA.
22. Trabolsi A, Epperla N, Annunzio K, Morgenstern Kaplan D, Doukas P, St-Pierre F, McCall B, Fitzgerald L, Han S, Reis I, Chapman-Fredricks J, Alhamad K, Ollila T, Karmali R, Lossos I, Alderuccio J. A multicenter study analyzing survival and prognostic factors in patients with leukemic phase follicular lymphoma. Presented at 65th American Society of Hematology Annual Meeting & Exposition; 2023 December 9, San Diego, CA.
23. Epperla N, Grover N, Annunzio K, Watkins M, Torka P, Karmali R, Anampa-Guzmán A, Oh T, Reves H, Tavakkoli M, Hansinger E, Christian B, Thomas C, Barta S, Ramakrishnan Geethakumari P, Bartlett N, Shouse G, Olszewski A. Impact of large cells and Ki-67% on outcomes in patients with newly diagnosed marginal zone lymphoma –results from a multicenter cohort study. Presented at 65th American Society of Hematology Annual Meeting & Exposition; 2023 December 9, San Diego, CA.
24. Ayers E, Zelikson V, Gurumurthi A, Sawalha Y, Annunzio K, Saha A, Dong N, Qualls D, Amoozgar B, Kahl B, Baird J, Challa P, Huntington S, Santos J, Bair S, Narkhede M, Li S, Frosch Z, Ho C, Smith S, Winter A, Landsburg D, Furqan F, Hamadani M, Baird K, Romancik J, Alharthy H, Law J, Bojanini L, Advani R, Hu B, Johnson P, Grover N, Kundu D, Merrill M, Crombie J, Shafagati N, Sterling C, Nastoupil L, Epperla N. Loncastuximab in high-risk and heavily-pretreated relapsed/refractory diffuse large b-cell lymphoma: a real world analysis from 21 US centers. Presented at 65th American Society of Hematology Annual Meeting & Exposition; 2023 December 9, San Diego, CA.
25. Annunzio K, McLaughlin E, Voorhees T, Shea L, Sumransub N, Rose A, Olszewski A, Bailey N, Patel K, Moyo T, Awan F, Ahmed G, Grover N, Adika A, Andres E, Faisal M, Christian B, Anna J, Bair S, Kendsersky N, Thomas C, Torka P, Svoboda J, Carter J, Hamadani M, Saeed H, Desai S, Evens A, Epperla N. Treatment Patterns and Outcomes for Patients with Classic Hodgkin Lymphoma (cHL) and Cardiomyopathy with Low Ejection Fraction (EF): Real-World Evidence (RWE) from 16 US Academic Centers. Presented at 65th American Society of Hematology Annual Meeting & Exposition; 2023 December 9, San Diego, CA.

© 2026 Clinical & Translational Science Institute
Medical College of Wisconsin
8701 Watertown Plank Road
Milwaukee, WI 53223

Publication and ontology data from NCBI | Disclaimer and Copyright

This site is a collaborative effort of the Medical College of Wisconsin and the Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number 2UL1TR001436) at the National Institutes of Health (NIH).

Faculty Collaboration Database

Profiles for MCW, MU, MSOE, UWM, BCW, CW, Froedtert, and VA Faculty